Special Issue "The 20th Anniversary of Pharmaceuticals—Emerging Trends in Biopharmaceuticals"
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Biopharmaceuticals".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 198
Special Issue Editors
Interests: antiviral nucleic acids; therapeutic RNA; aptamers; RNA inhibitors; structure/function of RNA; RNA viruses
Special Issues, Collections and Topics in MDPI journals
Interests: regulation of innate immunity; antimicrobial peptides; antifungal peptides; defensins; cathelicidins; novel antiviral compounds
Special Issues, Collections and Topics in MDPI journals
Interests: human pluripotent stem cell; stem cell differentiation; three-dimensional cell culture; organoid technology; tissue engineering; extracellular matrix; biomaterial; Endocrinology; functional maturation; cell-matrix interaction
Interests: organic chemistry; medicinal chemistry; carbohydrate and nucleos(t)ide chemistry; bioactive molecules; enzyme inhibitors; anticancer agents; antimicrobial agents; anti-Alzheimer’s agents
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to submit high-quality and relevant manuscripts on research activities in pharmaceutical technology for this Special Issue entitled “The 20th Anniversary of Pharmaceuticals—Emerging Trends in Biopharmaceutical Area”. All research will be included in a book dedicated to the 20th anniversary of our journal. Manuscripts focusing on the therapeutic, diagnostic, prognostic and immunoprophylactic developments of important biological macromolecules built from amino acids, sugars, nucleic acids, comprising small basic units of which they are composed, and mimetics produced by chemical synthesis. Contributions focusing on biopharmaceutical applications of more complex entities, such as phages, viruses, exosomes and stem cells, among others, are also welcome. Also reports on structure and molecular interactions determinant for biopharmaceuticals bioactivity or pharmaceutical applications, e.g. by computational and NMR studies are also accepted.
Dr. Alfredo Berzal-Herranz
Prof. Dr. Gill Diamond
Prof. Dr. Yan-Ru Lou
Dr. Nuno Manuel Xavier
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- proteins
- nucleic acids
- aptamers
- Glycans
- macromolecules
- antibodies
- phages
- viruses
- therapeutic tools
- peptidomimetics
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Prof. Juan C. Morales, CSIC - Instituto de Parasitologia y Biomedicina Lopez Neyra (IPBLN), Armilla, Spain
Dr. Kent Kirshenbaum, New York University, New York, NY, USA
